Remove Documentation Remove Immunization Remove Insurance
article thumbnail

Pharmacy Leaders Enhance Culture with Continuous Learning | McKesson ideaShare

Drug Topics

Kristen Jones, PharmD, AVP of professional liability strategic operations at the Pharmacists Mutual Insurance Company, discusses challenging traditional workplace paradigms by emphasizing the human element in pharmaceutical operations. Equally important is her emphasis on structured human resources practices.

article thumbnail

Q&A: Pharmacies Grapple With Patient Influx Amid Rite Aid Closures

Drug Topics

They look at the list and they prioritize who they want to take on and who they don't want to take on based on their insurance plan and their drugs. That's dependent upon their insurance plan and the medications they use. That means a robust immunization program for COVID-19, flu, shingles, pneumococcal and beyond.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How AI Brings Pharmacogenetics to the Frontline of Precision Medicine

Pharmacy Times

4 Though the US still stops short of requiring testing outright, this marks a critical turning point—shifting responsibility onto clinicians and paving the way for broader insurance coverage and adoption. Real-World Evidence, Emerging Therapies, and Demonstrating Value Technological advances are accelerating this progress.

article thumbnail

Navigating Rilonacept Therapy: Dose Adjustments, Discontinuation, and Patient Support Strategies

Pharmacy Times

We all share the same electronic health record and document every patient interaction in the health record, and we have very easy access to reach out to the patient's provider to let them know of any questions or concerns that the patient has regarding their medication.

article thumbnail

Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding

Pharmacy Times

Compliance with FDA guidelines, including documenting clinical differences and avoiding investigational GLP-1s, is essential for compounders. For example, a clinical notation that patient prefers compounded version because insurance will not pay is not acceptable. 6 A small sample of clinical differences is found in Table 3.

article thumbnail

Obesity Medication Use Remains Low Among Children | ADA 2025

Drug Topics

image credit: syahrir / stock.adobe.com While data shows that obesity has been on the rise among children in recent history, the overall complications spurred on by childhood obesity have been well documented. 1 “Guidelines recommend treating obesity with medications and lifestyle changes.”

article thumbnail

ADA 2025: Advancing CGM Adoption for Type 2 Diabetes Care

Pharmacy Times

Sayer primarily focuses on barriers to insurance coverage and the need for educational efforts among health care providers and patients. People want products reimbursed, and they're much more likely to use a product if it's paid for by the insurance system. We are getting insurance coverage.